1 World Health Organization, "World survey of rabies no. 32 for the year 1996. WHO document EMC/ZDI/98.4. World Health Organization, Geneva, Switzerland"
2 Wunner WH, "The molecular biology of rabies viruses" 10 : S771-S784, 1988
3 Lee JH, "Review of canine rabies prevalence under two diffe-rent vaccination programmes in Korea" 148 : 511-512, 2001
4 Aaslestad HG, "Recovery of protective activity in rabies virus vaccines concentrated and purified by four different methods" 24 : 37-43, 1972
5 Kang SY, "Reactivity of VP4-specific monoclonal antibodies to a serotype 4 porcine rotavirus with distinct serotypes of human (symptomatic and asymptomatic) and animal rotaviruses" 27 : 2744-2750, 1989
6 Cox JH, "Rabies virus glycoprotein. II. Biological and serological characterization" 16 : 754-759, 1977
7 Lodmell DL, "Rabies virus antinucleoprotein antibody protects against rabies virus challenge in vivo and inhibits rabies virus replication in vitro" 67 : 6080-6086, 1993
8 Hyun BH, "Molecular epidemiology of rabies virus isolates from South Korea" 114 : 113-125, 2005
9 Orlik O, "Modification of hybridoma technology which improve the yield of monoclonal antibody producing cells" 115 : 55-59, 1988
10 Brochier B, "Largescale eradication of rabies using recombinant vacciniarabies vaccine" 354 : 520-522, 1991
1 World Health Organization, "World survey of rabies no. 32 for the year 1996. WHO document EMC/ZDI/98.4. World Health Organization, Geneva, Switzerland"
2 Wunner WH, "The molecular biology of rabies viruses" 10 : S771-S784, 1988
3 Lee JH, "Review of canine rabies prevalence under two diffe-rent vaccination programmes in Korea" 148 : 511-512, 2001
4 Aaslestad HG, "Recovery of protective activity in rabies virus vaccines concentrated and purified by four different methods" 24 : 37-43, 1972
5 Kang SY, "Reactivity of VP4-specific monoclonal antibodies to a serotype 4 porcine rotavirus with distinct serotypes of human (symptomatic and asymptomatic) and animal rotaviruses" 27 : 2744-2750, 1989
6 Cox JH, "Rabies virus glycoprotein. II. Biological and serological characterization" 16 : 754-759, 1977
7 Lodmell DL, "Rabies virus antinucleoprotein antibody protects against rabies virus challenge in vivo and inhibits rabies virus replication in vitro" 67 : 6080-6086, 1993
8 Hyun BH, "Molecular epidemiology of rabies virus isolates from South Korea" 114 : 113-125, 2005
9 Orlik O, "Modification of hybridoma technology which improve the yield of monoclonal antibody producing cells" 115 : 55-59, 1988
10 Brochier B, "Largescale eradication of rabies using recombinant vacciniarabies vaccine" 354 : 520-522, 1991
11 Dietzschold B, "Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein" 9165-9169, 1987
12 Badrane H, "Host switching in lyssavirus history from the Chiroptera to the Carnivora orders" 75 : 8096-8104, 2001
13 Beran GW, "Handbook of Zoonoses" CRC Press 307-308, 1994
14 Lahaye X, "Functional characterization of Negri bodies (NBs) in rabies virus-infected cells: Evidence that NBs are sites of viral transcription and replication" 83 : 7948-7958, 2009
15 Towbin H, "Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications" 4350-4354, 1985
16 Blancou J, "Ecology and epidemiology of fox rabies" 10 : 606-609, 1988
17 Kohler G, "Continuous cultures of fused cells secreting antibody of predefined specificity" 256 : 495-497, 1975
18 Coyle PV, "A simple standardised protocol for the production of monoclonal antibodies against viral and bacterial antigens" 153 : 81-84, 1992